TRICORT 40MGML INJECTION
Država: Malezija
Jezik: angleščina
Source: NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)
Lastnosti izdelka
(SPC)
17-03-2023
Nekateri dokumenti za ta izdelek trenutno niso na voljo, pošljete lahko zahtevo v našo stranko in obvestili vas bomo takoj, ko jih bomo lahko pridobili.
Pošlji zahtevo.
Pošlji zahtevo.
Aktivna sestavina:
TRIAMCINOLONE ACETONIDE
Dostopno od:
PAHANG PHARMACY SDN. BHD.
INN (mednarodno ime):
TRIAMCINOLONE ACETONIDE
Enote v paketu:
1 Vials
Izdeluje:
CADILA PHARM LTD
Lastnosti izdelka
BACK SIDE
Pheochromocytoma crisis, which may be fatal, has been reported after
administration of systemic corticosteroids. Corticosteroids
should only be administered to patients with suspected or identified
pheochromocytoma after an appropriate risk/benefit evaluation.
OXXXXXXX
1389, Trasad Road, Dholka-382225,
Dist: Ahmedabad, Gujarat State, India. DATE OF REVISION:
15th March 2023
CO-TREATMENT WITH CYP3A INHIBITORS,
including cobicistat-containing products, is expected to increase the
risk of systemic side-
effects. The combination should be avoided unless the benefit
outweighs the increased risk of systemic corticosteroid side-effects,
in
which case patients should be monitored for systemic corticosteroid
side-effects.
Size : 120 x 400 mm
Export : Malaysia
Pantone P Black C
DG-15/03/23-V06
DG-18/11/22-V05
DG-28/07/22-V04
DG-21/07/22-V03
SS-29/11/18-V02
HV-10/10/16-V01
Preberite celoten dokument
